Fig 1.
CONSORT diagram for the DASISION trial after a minimum follow-up of 5 years. CML-CP, chronic myeloid leukemia in chronic phase; Ph+, Philadelphia chromosome positive. (*) Reasons for discontinuation are listed in Table 1.
CONSORT diagram for the DASISION trial after a minimum follow-up of 5 years. CML-CP, chronic myeloid leukemia in chronic phase; Ph+, Philadelphia chromosome positive. (*) Reasons for discontinuation are listed in Table 1.